These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25338303)

  • 1. E4BP4 is a repressor of epigenetically regulated SOSTDC1 expression in breast cancer cells.
    Rawat A; Gopisetty G; Thangarajan R
    Cell Oncol (Dordr); 2014 Dec; 37(6):409-19. PubMed ID: 25338303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E4BP4 promotes thyroid cancer proliferation by modulating iron homeostasis through repression of hepcidin.
    Zhou Q; Chen J; Feng J; Wang J
    Cell Death Dis; 2018 Sep; 9(10):987. PubMed ID: 30250199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E4BP4/NFIL3 modulates the epigenetically repressed RAS effector RASSF8 function through histone methyltransferases.
    Karthik IP; Desai P; Sukumar S; Dimitrijevic A; Rajalingam K; Mahalingam S
    J Biol Chem; 2018 Apr; 293(15):5624-5635. PubMed ID: 29467226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOSTDC1 down-regulation of expression involves CpG methylation and is a potential prognostic marker in gastric cancer.
    Gopal G; Raja UM; Shirley S; Rajalekshmi KR; Rajkumar T
    Cancer Genet; 2013 May; 206(5):174-82. PubMed ID: 23830730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac.
    Liu Y; Jin X; Li Y; Ruan Y; Lu Y; Yang M; Lin D; Song P; Guo Y; Zhao S; Dong B; Xie Y; Dang Q; Quan C
    J Exp Clin Cancer Res; 2016 Jul; 35(1):120. PubMed ID: 27461117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer.
    Clausen KA; Blish KR; Birse CE; Triplette MA; Kute TE; Russell GB; D'Agostino RB; Miller LD; Torti FM; Torti SV
    Breast Cancer Res Treat; 2011 Oct; 129(3):737-46. PubMed ID: 21113658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation.
    Wu Y; Alvarez M; Slamon DJ; Koeffler P; Vadgama JV
    BMC Cancer; 2010 Feb; 10():32. PubMed ID: 20132554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recruitment of histone methyltransferase G9a mediates transcriptional repression of Fgf21 gene by E4BP4 protein.
    Tong X; Zhang D; Buelow K; Guha A; Arthurs B; Brady HJ; Yin L
    J Biol Chem; 2013 Feb; 288(8):5417-25. PubMed ID: 23283977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XAF1 is frequently methylated in human esophageal cancer.
    Chen XY; He QY; Guo MZ
    World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/β-catenin pathway.
    Yang J; Han F; Liu W; Chen H; Hao X; Jiang X; Yin L; Huang Y; Cao J; Zhang H; Liu J
    J Exp Clin Cancer Res; 2017 Nov; 36(1):170. PubMed ID: 29183346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
    Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
    Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTHrP(1-34)-mediated repression of the PHEX gene in osteoblastic cells involves the transcriptional repressor E4BP4.
    Pellicelli M; Taheri M; St-Louis M; Bériault V; Desgroseillers L; Boileau G; Moreau A
    J Cell Physiol; 2012 Jun; 227(6):2378-87. PubMed ID: 21826652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of PAQR3 gene promoter hypermethylation in breast cancer and prognosis.
    Chen J; Wang F; Xu J; He Z; Lu Y; Wang Z
    Oncol Rep; 2016 Sep; 36(3):1612-8. PubMed ID: 27461225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECRG4 acts as a tumor suppressor gene frequently hypermethylated in human breast cancer.
    Tang GY; Tang GJ; Yin L; Chao C; Zhou R; Ren GP; Chen JY; Zhang W
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30918105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel E4BP4 element drives circadian expression of mPeriod2.
    Ohno T; Onishi Y; Ishida N
    Nucleic Acids Res; 2007; 35(2):648-55. PubMed ID: 17182630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic silencing of glutaminase 2 in human liver and colon cancers.
    Zhang J; Wang C; Chen M; Cao J; Zhong Y; Chen L; Shen HM; Xia D
    BMC Cancer; 2013 Dec; 13():601. PubMed ID: 24330717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TCF4/β-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer.
    Mostovich LA; Prudnikova TY; Kondratov AG; Gubanova NV; Kharchenko OA; Kutsenko OS; Vavilov PV; Haraldson K; Kashuba VI; Ernberg I; Zabarovsky ER; Grigorieva EV
    Epigenetics; 2012 Aug; 7(8):930-9. PubMed ID: 22805760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.